These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24767108)

  • 21. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Acta Neurol Scand; 2002 Jul; 106(1):39-43. PubMed ID: 12067327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.
    Dunjic-Kostic B; Ivkovic M; Radonjic NV; Petronijevic ND; Pantovic M; Damjanovic A; Poznanovic ST; Jovanovic A; Nikolic T; Jasovic-Gasic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():1-6. PubMed ID: 23200828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls.
    Loureiro CM; da Roza DL; Corsi-Zuelli F; Shuhama R; Fachim HA; Simões-Ambrosio LMC; Deminice R; Jordão AA; Menezes PR; Del-Ben CM; Louzada-Junior P
    Sci Rep; 2020 Dec; 10(1):21423. PubMed ID: 33293633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.
    Klumpers UM; Veltman DJ; Drent ML; Boellaard R; Comans EF; Meynen G; Lammertsma AA; Hoogendijk WJ
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):565-74. PubMed ID: 19890631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.
    Karolewicz B; Maciag D; O'Dwyer G; Stockmeier CA; Feyissa AM; Rajkowska G
    Int J Neuropsychopharmacol; 2010 May; 13(4):411-20. PubMed ID: 20236554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: A systematic review.
    Yang C; Tiemessen KM; Bosker FJ; Wardenaar KJ; Lie J; Schoevers RA
    J Psychosom Res; 2018 Aug; 111():58-68. PubMed ID: 29935756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic biosignature differentiates melancholic depressive patients from healthy controls.
    Liu Y; Yieh L; Yang T; Drinkenburg W; Peeters P; Steckler T; Narayan VA; Wittenberg G; Ye J
    BMC Genomics; 2016 Aug; 17(1):669. PubMed ID: 27549765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.
    Milak MS; Proper CJ; Mulhern ST; Parter AL; Kegeles LS; Ogden RT; Mao X; Rodriguez CI; Oquendo MA; Suckow RF; Cooper TB; Keilp JG; Shungu DC; Mann JJ
    Mol Psychiatry; 2016 Mar; 21(3):320-7. PubMed ID: 26283639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters.
    Kostera-Pruszczyk A; Niebroj-Dobosz I; Emeryk-Szajewska B; Karwańska A; Rowińska-Marcińska K
    Acta Neurol Scand; 2002 Jul; 106(1):34-8. PubMed ID: 12067326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
    Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
    BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global arginine bioavailability ratio is decreased in patients with major depressive disorder.
    Ali-Sisto T; Tolmunen T; Viinamäki H; Mäntyselkä P; Valkonen-Korhonen M; Koivumaa-Honkanen H; Honkalampi K; Ruusunen A; Nandania J; Velagapudi V; Lehto SM
    J Affect Disord; 2018 Mar; 229():145-151. PubMed ID: 29310063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal functional neuroimaging study in medication-naïve depression after antidepressant treatment.
    Tomioka H; Yamagata B; Kawasaki S; Pu S; Iwanami A; Hirano J; Nakagome K; Mimura M
    PLoS One; 2015; 10(3):e0120828. PubMed ID: 25786240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ratio of plasma BDNF to leptin levels are associated with treatment response in major depressive disorder but not in panic disorder: A 12-week follow-up study.
    An JH; Jang EH; Kim AY; Fava M; Mischoulon D; Papakostas GI; Na EJ; Jang J; Yu HY; Hong JP; Jeon HJ
    J Affect Disord; 2019 Dec; 259():349-354. PubMed ID: 31465895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
    Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
    Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
    Pech J; Forman J; Kessing LV; Knorr U
    J Affect Disord; 2018 Nov; 240():6-16. PubMed ID: 30041075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotransmitter amino acid in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Molina JA; Gómez P; Vargas C; Ortiz S; Pérez-Rial S; Urigüen L; Oliva JM; Villanueva C; Manzanares J
    J Neural Transm (Vienna); 2005 Apr; 112(4):557-63. PubMed ID: 15365790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of dansyl derivatization and chromatographic conditions in the determination of neuroactive amino acids of biological samples.
    Kang X; Xiao J; Huang X; Gu Z
    Clin Chim Acta; 2006 Apr; 366(1-2):352-6. PubMed ID: 16406032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
    Yoon HS; Hattori K; Sasayama D; Kunugi H
    J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.